- TNFA Dashboard
- Financials
- Filings
-
Holdings
- Transcripts
- ETFs
- Insider
- Institutional
- Shorts
-
S-1 Filing
TNF Pharmaceuticals (TNFA) S-1IPO registration
Filed: 7 Aug 13, 12:00am
Exhibit 99.1*
Consent of Director Nominee
In accordance with Rule 438 under the Securities Act of 1933, as amended (the “Securities Act”), the undersigned hereby consents to being named as a director nominee and impending board member of Akers Biosciences, Inc. (the “Company”) in the Company’s Registration Statement on Form S-1 (Registration No. 333-187094) and in all amendments (including post-effective amendments) thereto.
Dated: August 7, 2013
/s/Brandon Knox | ||
By: | Brandon Knox | |
Date: | August 7, 2013 |
We use cookies on this site to provide a more responsive and personalized service. Continuing to browse, clicking I Agree, or closing this banner indicates agreement. See our Cookie Policy for more information.